Background/Aims: An increasing number of studies have suggested that circular RNAs (circRNAs) have vital roles in carcinogenesis and tumor progression. However, the function of circRNAs in hepatocellular carcinoma (HCC) remains poorly characterized. Methods: We investigated the levels of circRNAs in patients with HCC to identify potential diagnostic biomarkers. We examined circRNA expression profiles in liver tumors and paired noncancerous liver tissues from three HCC patients with cancer thrombus using a circRNA microarray. Bioinformatics analysis was performed to find circRNAs with significantly altered expression levels between tumors and their paired non-tumor tissues. We confirmed our initial findings by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Receiver operating characteristic (ROC) curves were also applied to identify a candidate circRNA with the optimal specificity and sensitivity. Finally, X-tile software was adopted to calculate the most efficient cut-off value for hsa_circ_0091579 expression. Results: Microarray analysis identified 20 unique circRNAs that were differentially expressed between tumor and non-tumor tissues (P < 0.05). The expression of these 20 circRNAs was verified by qRT-PCR. The expression of hsa_circ_16245-1 and hsa_circ_0091579 mRNA was consistent with their levels as tested by the microarray. The ROC curves showed that both hsa_circ_16245-1 and hsa_circ_0091579 had favorable specificity and sensitivity. We further confirmed that hsa_circ_0091579 was significantly upregulated in HCC and its high expression was intimately associated with a worse overall survival in patients with HCC. Conclusion: Hsa_circ_0091579 may play a critical role in HCC progression and serve as a potential biomarker for the prognosis of patients with HCC.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most prevalent malignant tumor and ranks as the second most common cause of cancer-related death worldwide [1, 2] . Although the treatment and survival rate of patients with HCC has improved, most patients experience metastases and relapse within 5 years [3, 4] . Since HCC is a heterogeneous disease with the accumulation of genetic and epigenetic changes [5, 6] , it is critical to identify molecular biomarkers that can be used for its diagnosis and prognosis.
Circular RNAs (circRNAs), a unique form of RNA, possess covalently closed continuous loops without free ends; therefore, they are considerably more stable than linear RNAs [7] [8] [9] [10] . Accumulating evidence has revealed that circRNAs can act as microRNA (miRNA) "sponges" and regulate RNA-binding proteins to control the expression of genes encoding proteins [11] [12] [13] [14] . A growing number of studies have shown that the dysregulation of circRNA expression could have potential relationships with various human diseases such as systemic lupus erythematosus, diabetes mellitus, and Alzheimer's disease [15] [16] [17] . Recent studies have also revealed that circRNAs are involved in tumorigenesis, such as colon, gastric, and cervical cancer [18] [19] [20] [21] . However, the use of circRNAs for the diagnosis and prognosis of patients with HCC remains largely unknown. Recently, some studies have centered on the role of circRNAs in affecting the survival of patients with HCC [22] [23] . For instance, one study found that hsa_circ_0064428 was negatively correlated with the survival, tumor size, and metastasis of patients with HCC [24] . Besides, hsa_circ_0001445 has been reported to regulate the proliferation and migration of HCC and can serve as a diagnostic biomarker [25] . Furthermore, the oncogenic role of hsa_circ_0005075 has been confirmed since it was shown to promote HCC progression via the regulation of miR-431 [26] . Therefore, further screening and investigation of circRNAs in HCC are warranted.
In this study, we identified the differential expression profiles of circRNAs in three pairs of HCC clinical specimens with cancer thrombus using a circRNA microarray. We detected a total of 20 circRNAs with significantly different expression between tumor and non-tumor tissues. The altered expression of these circRNAs was verified using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. We verified and validated the increased expression of hsa_circ_0091579 in patients with HCC. Then, we showed the role of hsa_circ_0091579 in the prognosis of survival in a cohort of patients with HCC. In conclusion, our findings suggested that hsa_circ_0091579 may serve as a promising biomarker for the prognosis of patients with HCC.
Materials and Methods
Patients and samples A total of 105 HCC and paired adjacent non-cancerous tissue samples (30 in the training set and 75 in the validation set) were obtained from Fudan University Shanghai Cancer Center. The participants were recruited in January 2011. The samples were collected between January 1, 2011 and December 31, 2015. We conducted this study in January 2018. All patients included in this study gave their written informed consent prior to surgery. The study conformed with the code of ethics of the World Medical Association (Declaration of Helsinki). The samples were snap-frozen immediately in liquid nitrogen after resection and stored at −80℃ until RNA extraction. The diagnosis of HCC was confirmed pathologically. Three pairs of the samples were applied for microarray analysis, and 30 pairs were collected for qRT-PCR validation. We defined overall survival (OS) as the duration between diagnosis and death or between diagnosis and the last observation point. For surviving patients, the data were censored at the last follow-up. The use of human samples was approved by the Ethics Committee of Shangdong Cancer Hospital. We had access to personally identifying information of individual participants during and after data collection. 
RNA extraction and qRT-PCR
Total RNA was extracted from the HCC tissue samples and matched adjacent non-tumor tissues using the TRIzol reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. cDNA was synthesized with PrimeScript RT reagents (Takara Bio, Inc., Kusatsu, Japan). Primers for specific genes were designed and synthesized by Thinkgene Co. (Shanghai, China). The relative expression of circRNA was performed on an ABI Prism 7900 sequence detection system (Applied Biosystems, Foster City, CA). CircRNA expression was normalized to the expression of the housekeeping gene GAPDH.
CircRNA microarray hybridization and expression profiling
Microarray profiling was conducted by CapitalBio Technology Corporation (Beijing, China) using a human 8×15K CIRCRNA Array (Arraystar Technologies, Rockville, MD). Sample labeling, microarray hybridization, and washing were performed according to the manufacturer's standard protocols. Briefly, each purified RNA sample was transcribed to double-stranded cDNA, synthesized into cRNA, and labeled with Cy3-dCTP. The labeled cRNAs were hybridized with the CapitalBio Technology Human CircRNA Microarray. Next, the array was washed and scanned using an Agilent Scanner G2505C (KangChen Bio-tech, Shanghai, China). Quantile normalization of the raw data and subsequent data processing were performed using the R software package (R Version 3.1.2). CircRNAs with a fold change in expression ≥ 2.0 and P-value < 0.05 between the tumor and adjacent non-tumor tissues were considered statistically significant.
Primers for quantitative amplification of circRNAs
The sequences of these primers are listed in Table 1 .
X-tile analysis X-tile software was used to determine the optimal cut-off value of hsa_circ_0091579 expression according to the user's manual and previous studies [27] [28] .
Statistical analysis
Student's t-test was used to analyze differences in the expression of circRNAs between HCC and adjacent non-cancerous tissues. Spearman's rank correlation coefficient was utilized to calculate bivariate correlations. Receiver operating characteristic (ROC) curves were established to evaluate the diagnostic value of hsa_circ_0091579 and hsa_circ_16245-1. The Youden index, also known as the correct index, was applied to evaluate the authenticity of the screening test. Survival analysis was performed using the Kaplan-Meier method. Cox regression analyses were also performed to assess the association between hsa_ circ_0091579 and OS of HCC patients. The above statistical analyses were performed by using SPSS software package (version 22.0; SPSS, Inc., Chicago, IL) and GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA). X-tile software (version 3.5.0) was applied to determine the cut-off value of hsa_circ_0091579 expression. A P-value less than 0.05 was considered to be statistically significant. 
Results

Deregulated circRNAs in HCC tumor tissues
To investigate circRNA expression profiles in HCC tissues, we analyzed three pairs of HCC tissue samples (three HCC tissues and three matched non-tumor liver tissues) by using a circRNA microarray. Through expression intensity sorting within the HCC tumor and nontumor groups, the 20 most increased circRNAs in HCC tumor tissues as compared with those in non-tumor tissues are shown in Fig. 1A .
Validation of differentially expressed circRNAs by qRT-PCR
Among the 20 differentially expressed circRNAs, five circRNAs that were most highly expressed in HCC tissues were selected for validation using tumor and non-tumor tissues from 30 HCC patients by qRT-PCR. The expression of hsa_circ_15058-17 was not detected by qRT-PCR. As presented in Fig. 2 , the expression of hsa_circ_16245-1 and hsa_circ_0091579 was consistently and significantly increased in HCC tumor tissues, while there was no dramatic difference in the levels of hsa_circ_3424-4 and hsa_circ_15058-21 between HCC and paired adjacent non-tumor tissues.
Potential diagnostic value of hsa_circ_16245-1 and hsa_circ_0091579 in HCC
Since we found that hsa_circ_16245-1 and hsa_circ_0091579 levels were significantly increased in HCC tissues, we evaluated their potential diagnostic value. ROC curves were generated for hsa_circ_16245-1 and hsa_circ_0091579 levels in HCC. We found that the area under the ROC curve was 0.656 for hsa_circ_0091579 and 0.720 for hsa_circ_16245-1 (Fig.  3) . The sensitivity and specificity of hsa_circ_0091579 was 0.97 and 0.4, respectively. The sensitivity and specificity of hsa_circ_16245-1 was 0.83 and 0.63, respectively. To validate their prognostic value further, a total of 75 pairs of HCC samples were employed in a validation group. Hsa_circ_0091579 expression was found to be significantly increased in HCC tumor tissue as compared with that in adjacent non-tumor tissue; however, hsa_circ_16245-1 was not detected in some of the HCC samples (Fig. 4) . In addition, the sensitivity and specificity of hsa_circ_0091579 for diagnosis were also confirmed (Fig. 4) . 
Increased hsa_circ_0091579 expression is significantly correlated with poor prognosis in HCC patients
As hsa_circ_0091579 expression was significantly increased in HCC tissues, we next analyzed whether its increased expression correlated with the prognosis of patients with HCC. A cohort of HCC patients with survival data was included, and hsa_circ_0091579 expression was determined using in situ hybridization analysis of tissue array slides. Increased hsa_circ_0091579 expression in HCC tissues was significantly correlated with the poor prognosis of HCC patients (Fig. 5 ), shown as a Kaplan-Meier survival curve using the median value of hsa_circ_0091579 expression as the cut-off. Further correlation analysis demonstrated that there was no association between the levels of alpha fetoprotein (AFP) and hsa_circ_0091579. 
Cut-off value based on outcome and Kaplan-Meier analysis
Furthermore, we used X-tile software to calculate the most efficient cut-off value (30.9 × 10 -5 ) of hsa_circ_0091579 expression that could most significantly distinguish the outcome of patients with HCC patients (Fig. 6A, 6B) . OS was further analyzed using Kaplan-Meier analysis through this software. The results showed that HCC patients with relatively low hsa_circ_0091579 expression had improved OS compared with those with high expression (P < 0.05; Fig. 6C ). The P-value of OS based on the optimal cut-off point and a relative risk plot of HCC patients with high hsa_circ_0091579 expression compared with those with low expression are shown in Fig. 6D and Fig. 6E , respectively.
Together, these data suggest that increased hsa_circ_0091579 expression in HCC is correlated with the poor prognosis of patients, and the level of hsa_circ_0091579 expression may be useful for the prognosis of patients with HCC.
Discussion
The morbidity of HCC has been on the rise during the past few decades, especially in Asian countries [1] [2] . Thus, identifying markers for the diagnosis and prognosis of HCC is greatly needed.
CircRNAs were previously believed to possess no biological function [29] [30] ; however, both RNA deep sequencing technology and the development of bioinformatics have deepened our understanding of circRNAs. One study found that a series of circRNAs are aberrantly expressed in early-stage lung adenocarcinoma, which has made the early detection of lung cancer a possibility [31] . Another study revealed that a group of circRNAs specifically participate in the development of pancreatic ductal adenocarcinoma [32] .
As the expression and function of circRNAs during the development of HCC are still largely elusive, we screened for circRNAs that were differentially expressed between HCC tissues with cancer thrombus and paired tissues using a chip microarray. Then, we examined the expression of the top 20 circRNAs identified by the microarray, after which two circRNAs were chosen for further analysis. Since hsa_circ_0091579 was found to be more accurate than hsa_circ_16245-1 for prognosis, we focused on this circRNA for additional analysis.
Hsa_circ_0091579 expression was significantly increased in HCC and linked with an unfavorable prognosis in patients with HCC. By using X-tile software, we obtained an efficient cut-off value of 30.9 × 10 -5 for hsa_circ_0091579 to distinguish the outcome of patients with HCC. Although the exact applicable cut-off value still needs to be confirmed in a large set of patients, this cut-off value for hsa_circ_0091579 is somewhat practical for the prognosis of HCC patients. However, the increased expression of hsa_circ_0091579 was not associated with serum AFP level, tumor diameter, differentiation, Barcelona Clinic Liver Cancer stage, and tumor-node-metastasis stage in HCC in our study (data not shown). This may be due to the complex tumor microenvironment and the relatively small sample size examined. Currently, a series of circRNAs, e.g., hsa_circ_0005075, hsa_circ_0004018, and hsa_circ_0003570, have been demonstrated to influence the development and prognosis of HCC [33] [34] [35] . However, conclusive or practical criteria for the prognosis of HCC still require further investigation.
In circBase, which is a database for circRNAs, it has been shown that hsa_circ_0091579 regulates the glypican-3 protein (GPC3) gene. GPC3 is a member of the heparan sulfate proteoglycan family. It is normally detected in placenta, numerous embryonic tissues, adult ovary, mammary gland, mesothelium, lung, and kidney, while no GPC3 expression can be detected in healthy adult liver [36] [37] . Previous studies have demonstrated a dramatic increase in GPC3 levels in both serum and tumor tissue in HCC [38] . Multiple mechanisms may account for the involvement of GPC3 in the progression of HCC, including Wnt signaling activation, macrophage recruitment, cell growth, and the promotion of epithelial to mesenchymal transition [39] [40] [41] [42] [43] . It is also noteworthy that by sequestering miRNAs, circRNAs are major players in the miRNA-mediated regulation of corresponding mRNA and gene expression, and are therefore closely related to the development of various human cancers. For example, the circRNA ciRS-7/CRD1as contains multiple, tandem miR-7 binding sites, and, thereby, acts as an endogenous miRNA sponge to adsorb, and hence quench, the normal functions of miR-7 [44] [45] . To the best of our knowledge, four miRNAs (miR-96, miR-1271, miR-520c-3p, and miR-219-5p) have been shown to regulate GPC3 expression negatively [46] [47] [48] [49] . Therefore, we speculate that hsa_circ_0091579 might competitively bind with miR-96, miR-1271, miR-520c-3p, and miR-219-5p and abrogate their effects. The interactions between hsa_circ_0091579 and the above miRNAs remain largely unknown and require further research.
As reported previously, some non-coding RNAs are stable in plasma, while some circRNAs are abundant in exosomes [50] [51] . Whether hsa_circ_0091579 can also be detected in the plasma or even in circulating exosomes and whether circulating hsa_circ_0091579 is also associated with HCC development and prognosis are critical questions that require further investigation in the future.
The findings of this study could be utilized in clinical practice for the diagnosis and prognosis of patients with HCC. Prognosis could be largely determined by the detection of hsa_circ_0091579 in tumors from HCC patients. Therefore, different treatments could be designed for HCC patients with different expression levels of hsa_circ_0091579. Thus, individual-oriented therapy could be achieved. 
Conclusion
To conclude, our study revealed the overexpression of hsa_circ_0091579 in HCC tissues as compared with their adjacent non-tumor tissues, and increased hsa_circ_0091579 expression was linked with worse OS in patients with HCC. However, a relatively larger study should be performed to confirm our findings further so that hsa_circ_0091579 expression can be applied in the clinical setting in the future.
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